A double blind,double dummy,randomized,controlled trial of ibudilast sustained-release capsule in treatment of asthma or chronic as thmatic bronchitis
XIONG Sheng-dao
LIU Hui-guo
ZHANG Zhen-xiang
XU Yong-jian
Abstract：Objective:To evaluate the efficacy and safety of ibudila st sustained-release capsule in treatment of asthma or chronic asthmatic bronch itis.Methods:80 patients with asthma or chronic asthmatic bronchitis w ere randomly allocated to receive twice daily 10 mg ibudilast sustained-release capsule for 6 weeks or three times daily 100 mg tranilast sustained-release ca psule for 6 weeks.Results:The total significantly effective rate,total effective rate,improvement in lung function and decrease in IgE value obtained were similar in both active and control groups.Conclusion:Ibudilast su stained-release capsule is an effective agent for treatment of asthma or chroni c asthmatic bronchitis.
Machine-generated Keywords：
Publication Date：2001-01-01
Online Publishing Date：2026-08-14(First online date of this platform, not the publication date of the document)
Pages：3( 113-115 )